<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="world, where the Africa region accounted for 93% of all" exact="malaria" post="cases and 94% of malaria deaths [2]. Most often,"/>
 <result pre="accounted for 93% of all malaria cases and 94% of" exact="malaria" post="deaths [2]. Most often, pregnant women and children under"/>
 <result pre="affected [3]. For instance, from the total deaths due to" exact="malaria" post="in 2018, 67% or 272,000 were children under 5Â"/>
 <result pre="or one child under five every two minutes dies of" exact="malaria" post="in 2018 alone and most of these deaths occurred"/>
 <result pre="morbidity and mortality is almost certainly the increasing resistance of" exact="malaria" post="parasites to available drugs [4]. In Ethiopia, there has"/>
 <result pre="has been success in the past recent years to reduce" exact="malaria" post="burden. However, it is still prevalent in 75% of"/>
 <result pre="of morbidity [6]. In addition, 8% of global Plasmodium vivax" exact="malaria" post="cases occur in Ethiopia [2]. Hence, the fight against"/>
 <result pre="malaria cases occur in Ethiopia [2]. Hence, the fight against" exact="malaria" post="in Ethiopia remains a public health priority. Natural products"/>
 <result pre="foliosa are traditionally used for the treatment of abdominal cramps," exact="malaria" post="and wounds [15]. Previously, six in vitro active anti-malarial"/>
 <result pre="100Ã—â€‰magnification power [21, 23, 29]. Mean percent parasitaemia and percent" exact="suppression" post="were calculated using the following formulae. \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym}"/>
 <result pre="ANOVA followed by Tukey post hoc test to compare percent" exact="suppression" post="(activity), mean survival time and percent changes in body"/>
 <result pre="be regarded as good since it showed greater than 50%" exact="suppression" post="at a dose of 200Â mg/kg. Previous studies demonstrated"/>
 <result pre="with Plasmodium berghei Test substances Dose (mg/kg/day) Percent parasitaemia Percent" exact="suppression" post="Mean survival time (in days) Vehicle1 0.2Â ml 35.9860â€‰Â±â€‰1.22034"/>
 <result pre="Kniphofia folosia in mice infected with Plasmodium berghei in 4-day" exact="suppression" post="test. Values are presented as meanâ€‰Â±â€‰SEM; nâ€‰=â€‰5 Among the"/>
 <result pre="infected mice (Table 4). Although knipholone and dianellin showed significant" exact="suppression" post="at all dose levels tested, the former displayed superior"/>
 <result pre="dose levels tested, the former displayed superior activity with percent" exact="suppression" post="values of 55.14 and 60.16% at doses of 100"/>
 <result pre="with Plasmodium berghei Test substances Dose (mg/kg/day) Percent parasitaemia Percent" exact="suppression" post="Mean survival time (in days) Vehicle3 Knipholone 0.2Â ml"/>
 <result pre="knipholone and dianellin, there were significant differences in percent parasite" exact="suppression" post="among the treatment groups. However, there was no significant"/>
 <result pre="of interest. References References 1.CowmanAFHealerJMarapanaDMarshKMalaria: biology and diseaseCell201616761062410.1016/j.cell.2016.07.05527768886 2.collab: WHOWorld" exact="malaria" post="report 20192019GenevaWorld Health Organization 3.SnowRWSartoriusBKyaloDMainaJAmratiaPMundiaCWet al.The prevalence of Plasmodium"/>
 <result pre="4.FarooqUMahajanRCDrug resistance in malariaJ Vector Borne Dis200441455315672556 5.collab: WHO. World" exact="malaria" post="reportCountry profile: Ethiopia2017GenevaWorld Health Organization2017 6.TadesseFFogartyAWDeressaWPrevalence and associated risk"/>
 <result pre="profile: Ethiopia2017GenevaWorld Health Organization2017 6.TadesseFFogartyAWDeressaWPrevalence and associated risk factors of" exact="malaria" post="among adults in East Shewa Zone of Oromia Regional"/>
 <result pre="antimalarial activity of extracts from three medicinal plants used in" exact="malaria" post="treatment in NigeriaParasitol Res201611529930510.1007/s00436-015-4747-x26391173 43.AlsonSGJansenOCieckiewiczERakotoarimananaHRafatroHDegotteGet al.In vitro and in"/>
 <result pre="natural and synthetic origin as promising drugs against the human" exact="malaria" post="parasite Plasmodium falciparum: structure-activity relationshipsParasitol Res19998558258810.1007/s00436005059810382608 51.IgnatushchenkoaMVWinterRWBÃ¤chingerHPHinrichsDJRiscoeMKXanthones as antimalarial"/>
</results>
